Celltrion completed a 100 billion won treasury stock acquisition between October 27 and November 11, purchasing 501,329 common shares according to a November 13 filing with the Financial Supervisory Service's electronic disclosure system. The biopharmaceutical company finished the buyback program two months ahead of its original January 26 deadline, with the total acquisition cost reaching 100.013 billion won. The purchase increased Celltrion's treasury stock holdings to 1,636,735 shares representing 0.71% of issued shares, with a book value of approximately 303.9 billion won, as Korean stocks saw active corporate buyback activity in recent months.
Celltrion Executes Daily Share Purchases at Varying Prices
Celltrion purchased 60,000 shares on the first day (October 27) and 50,000 shares on October 28, then executed orders for 40,000 shares per trading day through November 10. The average acquisition price per share was 199,470 won. Daily average prices ranged from a low of 189,780 won on October 29 to a high of 214,511 won on November 5, reflecting stock price movements during the purchase period. The company stated that the difference between the planned acquisition amount of 100.001376 billion won (disclosed in the October 26 major matters report) and the actual acquisition amount resulted in a discrepancy of less than one share due to price fluctuations during the acquisition period.
Treasury Stock Holdings Reach 2.17% of Issued Shares
Following this purchase, Celltrion's treasury stock stands at 1,636,735 shares, representing 0.71% of total issued shares with a book value of approximately 303.9 billion won. When combined with separately held treasury stock of 3,396,578 shares, the company's total treasury stock reaches 5,033,313 shares, equivalent to 2.17% of total issued shares.
FAQ
What was Celltrion's average purchase price during the buyback?
Celltrion's average acquisition price was 199,470 won per share during the October 27 to November 11 buyback period.
How much earlier did Celltrion complete the buyback compared to the original deadline?
Celltrion completed the 100 billion won buyback two months ahead of the original January 26 deadline, finishing on November 11.